Skip to main content

CARLSMED, INC.

Data quality: 83%
CARL
Nasdaq Manufacturing Measuring & Analyzing Instruments
$9.65
▼ $0.35 (-3.45%)
Mkt Cap: 257.96 M
Price
$9.65
Mkt Cap
257.96 M
Day Range
$9.51 — $9.82
52-Week Range
$8.87 — $17.19
Volume
21,269
Open $9.59
50D / 200D Avg
$11.70
17.51% below
50D / 200D Avg
$12.93
25.35% below

Quick Summary

Key Takeaways

Debt/Equity of 0.14 — conservative balance sheet
Negative free cash flow of -29.62 M

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-251.27%
Below sector avg (-53.47%)
ROIC-28.80%
Net MarginN/A
Op. MarginN/A

Safety

Debt / Equity
0.14
Below sector avg (0.31)
Current Ratio12.03
Interest Coverage-21.38

Valuation

PE (TTM)
-8.70
Below sector avg (-1.47)
P/B Ratio2.42
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)
Metric Stock Sector Median
P/E -8.7 -1.5
P/B 2.4 1.6
ROE % -251.3 -53.5
Net Margin % -41.5
Rev Growth 5Y % 1.8
D/E 0.1 0.3

ETFs Holding This Stock

JANVX JANVX
0.26% weight
JAVTX JAVTX
0.26% weight
JVTCX JVTCX
0.26% weight
JVTAX JVTAX
0.26% weight
JVTIX JVTIX
0.26% weight
JVTSX JVTSX
0.26% weight
JVTNX JVTNX
0.26% weight

All Fundamental Metrics

Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -29.63 M
ROE -251.27% ROA -31.50%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -29.62 M
ROIC -28.80% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.14 Current Ratio 12.03
Interest Coverage -21.38 Asset Turnover N/A
Working Capital 120.54 M Tangible Book Value 106.66 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -8.70 Forward P/E N/A
P/B Ratio 2.42 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -11.48%
Market Cap 257.96 M Enterprise Value 158.03 M
Per Share
EPS (Diluted TTM) -2.12 Revenue / Share N/A
FCF / Share -1.11 OCF / Share -1.08
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 99.95%
SBC-Adj. FCF -31.55 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025
Revenue
Net Income -29.63 M
EPS (Diluted) -2.12
Gross Profit 38.04 M
Operating Income -30.57 M
EBITDA
R&D Expenses 17.02 M
SG&A Expenses
D&A 281,000.0
Interest Expense 1.43 M
Income Tax 0.0

Balance Sheet

Annual, most recent first
Metric FY2025
Total Assets 130.12 M
Total Liabilities 31.25 M
Shareholders' Equity 98.87 M
Total Debt 15.35 M
Cash & Equivalents 85.79 M
Current Assets 126.67 M
Current Liabilities 14.28 M